MGMT promoter methylation in pediatric high-grade gliomas.
Matteo
M
Fassan
Evelyne
E
Tassone
Maurizio
M
Onisto
Giorgio
G
Perilongo
Domenico
D
D'Avella
Marina Paola
MP
Gardiman
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000235:genetics* / Q000628:therapy; D002648:Child; D003131:Combined Modality Therapy; D019175:DNA Methylation / Q000235:genetics*; D015254:DNA Modification Methylases / Q000235:genetics*; D045643:DNA Repair Enzymes / Q000235:genetics*; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D005260:Female; D005910:Glioma / Q000235:genetics* / Q000628:therapy; D006801:Humans; D008297:Male; D019635:Neurosurgical Procedures; D011401:Promoter Regions, Genetic / Q000235:genetics*; D011878:Radiotherapy; D000077204:Temozolomide; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins / Q000235:genetics*
D000970:Antineoplastic Agents; D025521:Tumor Suppressor Proteins; D003606:Dacarbazine; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes; D000077204:Temozolomide